{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:37:04Z","timestamp":1784230624742,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To analyze and determine the safety and efficacy of growth hormone (GH) treatment in Down syndrome (DS) pediatric patients and to weigh ethical aspects involved.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Systematic review and mini meta-analysis of the literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A search was performed in PubMed, Embase, Scopus, and PsycINFO through August 2022. Eligible studies included those who answered at least one of the following two questions: 1) What is the effect of growth hormone treatment in children with Down syndrome? 2) What are the ethical arguments in favor and against growth hormone treatment for children with Down syndrome? Multiple reviewers independently screened each article for eligibility.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total sixteen reports detailed medical effects of GH treatment in pediatric DS patients and eight studies dealt with ethical aspects of GH treatment. Treatment with GH resulted in significantly higher growth velocity in patients with DS. The ethical complexity is great but does not present insurmountable difficulties to the therapeutic option.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>As GH treatment is safe and effective for short-term height growth, GH therapy should be considered in long-term treatment of DS children.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1135768","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T05:00:39Z","timestamp":1682053239000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["GH treatment in pediatric Down syndrome: a systematic review and mini meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"David","family":"Shaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Hershkovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Tamam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadi","family":"Bollotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odeya","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Yalovitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neta","family":"Loewenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Carmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dganit","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Haim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.06.013","article-title":"Current estimate of down syndrome population prevalence in the united states","volume":"163","author":"Presson","year":"2013","journal-title":"J Pediatr"},{"key":"B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/9781681081342115010004","article-title":"Epidemiology and prevalence of down syndrome","volume-title":"Down syndrome children - an update","author":"Al-Biltagi","year":"2015"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1542\/peds.81.1.102","article-title":"Growth charts for children with down syndrome: 1 month to 18 years of age","volume":"81","author":"Cronk","year":"1988","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1132296","article-title":"GHRH-GH-IGF1 axis in pediatric down syndrome: a systematic review and mini meta-analysis","volume":"11","author":"Shaki","year":"2023","journal-title":"Front Pediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(87)80395-5","article-title":"Life expectancy in down syndrome","volume":"110","author":"Baird","year":"1987","journal-title":"J Pediatr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: a new tool to assess risk of bias in systematic reviews was developed","volume":"69","author":"Whiting","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(05)80266-5","article-title":"Growth hormone therapy in children with down syndrome","author":"Binder","year":"1992","journal-title":"J Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/s0022-3476(05)80267-7","article-title":"Growth hormone therapy in children with down syndrome","volume":"120","author":"Underwood","year":"1992","journal-title":"J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(05)80849-2","article-title":"Growth hormone for children with down syndrome","volume":"123","author":"Allen","year":"1993","journal-title":"J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-6374(00)80017-9","article-title":"Growth hormone therapy for prader-Willie and down syndromes: a post-modern medical dilemma","volume":"10","author":"Lantos","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(05)80463-9","article-title":"Growth hormone therapy for children with down syndrome [6]","volume":"120","author":"Allen","year":"1992","journal-title":"J Pediatr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(94)70277-2","article-title":"Growth hormone treatment in down syndrome [1]","volume":"124","author":"Castells","year":"1994","journal-title":"J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0022-3476(05)83316-5","article-title":"Treatment of poor growth in children with down syndrome","volume":"125","author":"Duffey","year":"1994","journal-title":"J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/00008480-199608000-00018","article-title":"Ethical issues in emerging new treatments such as growth hormone therapy for children with down syndrome and prader-willi syndrome","volume":"8","author":"Kodish","year":"1996","journal-title":"Curr Opin Pediatr"},{"key":"B18","article-title":"Little bigger, little better","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"B19","article-title":"Recombinant human growth hormone treatment in down syndrome: the troina experience","volume":"9","author":"Ragusa","year":"1996","journal-title":"Dev Brain Dysfunction"},{"key":"B20","first-page":"59","article-title":"Growth disorders in down\u2019s syndrome: growth hormone treatment","volume":"27","author":"Pallotti","year":"2002","journal-title":"Minerva endocrinologica"},{"key":"B21","article-title":"Long-term effects of recombinant human growth hormone on children with down syndrome and growth retardation","volume":"9","author":"Castells","year":"1996","journal-title":"Dev Brain Dysfunction"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.1993.tb00881.x","article-title":"Normalized growth velocity in children with down\u2019s syndrome during growth hormone therapy","volume":"37","author":"Anneren","year":"1993","journal-title":"J INTELLECT Disabil Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(05)82068-2","article-title":"Treatment of children with down syndrome and growth retardation with recombinant human growth hormone","volume":"119","author":"Torrado","year":"1991","journal-title":"J Pediatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1297\/cpe.22.65","article-title":"Therapeutic efficacy and safety of GH in Japanese children with down syndrome short stature accompanied by GH deficiency","volume":"22","author":"Meguri","year":"2013","journal-title":"Clin Pediatr Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/adc.61.1.48","article-title":"Growth and somatomedin responses to growth hormone in down\u2019s syndrome","volume":"61","author":"Anner\u00e9n","year":"1986","journal-title":"Arch Dis Child"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/adc.80.4.334","article-title":"Growth hormone treatment in young children with down\u2019s syndrome: effects on growth and psychomotor development","volume":"80","author":"Anner\u00e9n","year":"1999","journal-title":"Arch Dis Child"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2009.01679.x","article-title":"Late effects of early growth hormone treatment in down syndrome","volume":"99","author":"Myrelid","year":"2010","journal-title":"Acta Paediatrica Int J Paediatrics"},{"key":"B28","article-title":"Growth hormone neuropathology in down syndrome (trisomy 21)","volume":"9","author":"Wisniewski","year":"1996","journal-title":"Dev Brain DYSFUNCTION"},{"key":"B29","article-title":"The effect of growth hormone therapy on growth and mental development in children with down sydrome","volume":"9","author":"Anner\u00e9n","year":"1996","journal-title":"Dev Brain DYSFUNCT"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-6374(00)80016-7","article-title":"Growth hormone therapy in young children with down syndrome and a clinical comparison of down and prader-willi syndromes","volume":"10","author":"Anner\u00e9n","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"B31","article-title":"The effect of growth hormone therapy on craniofacial growth and dental maturity in children with down syndrome","volume":"19","author":"Carlstedt","year":"1999","journal-title":"J Craniofacial Genet Dev Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1297\/cpe.10.137","article-title":"Beneficial effect of growth hormone on severe delay in motor development in a child with down syndrome","volume":"10","author":"Yasuhara","year":"2001","journal-title":"Clin Pediatr Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350768","article-title":"Growth hormone administration normalizes the ovarian responsiveness to follicle-stimulating-hormone in the early stages of the follicular maturation in women with down syndrome","volume":"21","author":"Cento","year":"1998","journal-title":"J Endocrinological Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.107.448.475","article-title":"Treatment of mongolism with pituitary extract","volume":"107","author":"Berg","year":"1961","journal-title":"J Ment Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.21037\/tp-21-424","article-title":"Relationship between growth and intelligence quotient in children with down syndrome","volume":"11","author":"K\u0142osowska","year":"2022","journal-title":"Transl Pediatr"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03126.x","article-title":"Mental and motor development before and during growth hormone treatment in infants and toddlers with prader-willi syndrome","volume":"68","author":"Festen D a.","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111883","article-title":"IGF1 deficiency integrates stunted growth and neurodegeneration in down syndrome","volume":"41","author":"Araya","year":"2022","journal-title":"Cell Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/jar.12182","article-title":"Employment in adults with down syndrome in the united states: results from a national survey","volume":"29","author":"Kumin","year":"2016","journal-title":"J Appl Res Intellect Disabil"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2021.101392","article-title":"Impact of short stature on quality of life: a systematic literature review","author":"Backeljauw","year":"2021","journal-title":"Growth Horm IGF Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1135768\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T05:00:44Z","timestamp":1682053244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1135768\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":39,"alternative-id":["10.3389\/fendo.2023.1135768"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1135768","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"article-number":"1135768"}}